epitkane Profile Banner
Esa Pitkänen Profile
Esa Pitkänen

@epitkane

Followers
489
Following
995
Media
12
Statuses
262

Machine learning the cancer genome and other puzzles at @mlbiomed @FIMM_UH @ATGprogram @ican_finland

Helsinki, Finland
Joined February 2009
Don't wanna be here? Send us removal request.
@epitkane
Esa Pitkänen
2 years
RT @Merijellona: It's Fragment Friday! Happy to share our thoughts on #ctDNA #fragmentomics with @epitkane and @LeppaSM in the latest ctDNA….
0
4
0
@epitkane
Esa Pitkänen
2 years
@PrimaSanjaya @FIMM_UH @ATGprogram @iCAN_Finland An earlier thread on the key results: For the revision, we validated MuAt in extended WGS cohorts together with @GenomicsEngland and @AaltonenLab - huge thanks!.
@epitkane
Esa Pitkänen
3 years
Excited to announce our new manuscript on tumor (sub)typing in NGS data! Wonderful work by @PrimaSanjaya in collab with @sebastianw @OliverStegle @JanKorbel5 @FIMM_UH @ATGprogram @mlbiomed
0
0
0
@grok
Grok
1 day
Join millions who have switched to Grok.
100
183
1K
@epitkane
Esa Pitkänen
2 years
Wonderful to see our work on (deep) learning how to classify tumor types with WGS/WES data published in Genome Medicine! Great effort by @PrimaSanjaya and coauthors to validate the method in >10,000 whole cancer genomes. @FIMM_UH @ATGprogram @iCAN_Finland
genomemedicine.biomedcentral.com
Background Cancer genome sequencing enables accurate classification of tumours and tumour subtypes. However, prediction performance is still limited using exome-only sequencing and for tumour types...
2
9
36
@epitkane
Esa Pitkänen
2 years
RT @FIMM_UH: Are you our new Group Leader?.We will recruit early-stage group leaders in molecular medicine with notable international exper….
helsinki.fi
We are inviting outstanding candidates for the position of Group Leader in Molecular Medicine with an initial 5-year appointment and the opportunity for a 4-year extension following the EMBL model....
0
10
0
@epitkane
Esa Pitkänen
2 years
Fantastic work from our collaborators @waaralab on this intriguing hematological disease.
@OKilpivaara
Outi Kilpivaara
2 years
I’m overjoyed to share our collaborative work on ERCC6L2 disease. @BloodJournal @ASH_hematology. A must read for all hematologists! @MarjaHak @ullawk @waaralab @ATGprogram @HelsinkiUniMed Check out also a stellar commentary by @marrowgenes.
0
0
6
@epitkane
Esa Pitkänen
2 years
Thread on our key results
@epitkane
Esa Pitkänen
3 years
How to virtually label cells with imaging flow cytometry (IFC) and identify cell types? @TimonenVeera created DeepIFC to solve this problem. Great collaboration with Finnish Red Cross Blood Service @Veripalvelu @FIMM_UH @ATGprogram @helsinkiuni @mlbiomed
0
0
1
@epitkane
Esa Pitkänen
2 years
Happy to see our paper on reconstructing fluorescent labels in imaging flow cytometry with deep learning published. Excellent work by @TimonenVeera and collaborators! @frcbsresearch @mlbiomed @FIMM_UH
onlinelibrary.wiley.com
Imaging flow cytometry (IFC) combines flow cytometry with microscopy, allowing rapid characterization of cellular and molecular properties via high-throughput single-cell fluorescent imaging....
1
6
16
@epitkane
Esa Pitkänen
3 years
RT @mkuijjer: Would you like to develop your own research line, on the interface of network science, computational tool development, and ca….
0
22
0
@epitkane
Esa Pitkänen
3 years
We have exciting opportunities in @iCAN_Finland for bioinformaticians and clinical data analysts to transform large-scale molecular profiling and health registry data into breakthroughs in precision cancer medicine!
jobs.helsinki.fi
Clinical Data Analyst to join the iCAN Digital Precision Cancer Medicine project
0
3
13
@epitkane
Esa Pitkänen
3 years
RT @paula_jouhten: The cool yeasts are tacking to progress against wind or analogously natural selection.
0
4
0
@epitkane
Esa Pitkänen
3 years
RT @MirttiTuomas: Cancer research, histomics and multiomics well presented in the first Finnish LUMI supercomputer….
0
3
0
@epitkane
Esa Pitkänen
3 years
RT @SWedenoja: Katsauksemme valottaa ongelmia, joita #toisiolaki aiheuttaa rekisteritutkimukselle ja -yhteistyölle @THLorg @HelsinkiUniMed….
0
9
0
@epitkane
Esa Pitkänen
3 years
DeepIFC code and trained models are available at You can browse our data interactively at
github.com
Contribute to timonenv/DeepIFC development by creating an account on GitHub.
1
0
3
@epitkane
Esa Pitkänen
3 years
Thank you to the Academy of Finland @SuomenAkatemia for supporting this work, and to all co-authors! @EKerkela Ulla Impola @LeenaPenna @JukkaPartanen1 @OKilpivaara @miarvas.
1
0
5
@epitkane
Esa Pitkänen
3 years
DeepIFC was trained on IFC images acquired from mononuclear cells. To see if DeepIFC was able to distinguish a previously unseen cell type, we analyzed an independent set of red blood cells. These cells were recognized as a separate cell type. #zeroshot #representationlearning
Tweet media one
1
0
1
@epitkane
Esa Pitkänen
3 years
IFC images sometimes contain more than one cell, allowing investigation of potential cell-cell interactions. DeepIFC was able to reconstruct surface marker fluorescence for individual cells in doublet events. We observed 2x more monocytes in doublets than expected.
Tweet media one
1
0
2
@epitkane
Esa Pitkänen
3 years
We classified cells by gating virtually labeled cells. Balancing training data improved prediction of especially NK, NKT, cytotoxic T and B cells, which were otherwise difficult to predict. For example, data balancing improved F1 score for NKT cells from 0.22 to 0.71.
1
0
3
@epitkane
Esa Pitkänen
3 years
We evaluated DeepIFC trained on 247k IFC images by virtually labeling mononuclear cells. Cell surface markers CD45, CD3 and CD14, and dead/damaged cell marker 7-AAD were reconstructed well, while CD19, CD8 and CD56 proved more difficult.
Tweet media one
1
0
4
@epitkane
Esa Pitkänen
3 years
DeepIFC is based on Inception U-Net architecture - popular model in cross-modality learning - to reconstruct fluorescent images from brightfield and darkfield images. Cell types are predicted by virtually gating reconstructed images.
Tweet media one
1
0
4